Bryn Mawr, Pennsylvania Clinical Research Trials

Found 85 clinical trials

For pediatric ages
For Seniors
Recruiting in 100s
Interventional Study
all
Recruiting

Reduced Radiation Dose and IR-impact on Coronary Calcium Quantification

Evaluation of reduced radiation dose iterative reconstruction reconstructions for calcium scoring compared to full dose filtered back projection reconstructions

University of Pennsylvania

(8.4 away) Contact site

0 views
19 Feb, 2024
1 location

For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients

This is a pilot study using cytotoxic T lymphocytes (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Gamma-capture system will be effective in decreasing specific viral load in patients with BK virus viremia and BK virus-associated symptoms post-allogeneic hematopoietic stem cell transplantation (HSCT), renal transplantation, and chemotherapy.

Children's Hospital of Philadelphia

(8.4 away) Contact site

0 views
19 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

blood test

covid-19

Temple Univ School of Med

(9.6 away) Contact site

0 views
19 Feb, 2024
+10 other locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

This will be a phase 1a randomized, open label, multi-center study with approximately 24 subjects. All subjects will receive standard of care (SOC) per institutional guidelines for treatment of hospitalized patients with COVID-19 infection. In addition to SOC, the brequinar group will receive 5 daily doses of brequinar 100 mg.

pao2

headache

myalgia

FIO2

cough

Temple University

(9.6 away) Contact site